For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Eli Lilly (NYSE:LLY) drew attention on Friday after JPMorgan reiterated its bullish stance on the stock, raising its price ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

Internalised and external weight stigma plays a major role in mental distress. Fat-shaming, negative stereotypes, and biased treatment contribute to feelings of shame, loneliness, and hopelessness—all ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Prenatal and early-life factors significantly influence childhood obesity trajectories, highlighting the need for early ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.